Lung Cancers Today· @Lung_Cancers · X·· 17 hours agoScore70
Body
⏰️ Coming up at #ESMO26: The first @myESMO Presidential Symposium kicks off at 4:30 PM CEST!
🫁 The session features the DeLLphi-305 trial, presented by @sands_jacob of @DanaFarber, followed by a discussant by @StephenVLiu!
➡️ Stay tuned: https://buff.ly/2cB3hqq
#SCLC
39 views · 0 likes · 0 reposts · 0 replies
Conference abstracts
LBA3matched by Presidential Symposium I
Tarlatamab plus durvalumab (durva) vs durva as 1L maintenance (1LM) therapy following durva, platinum, and etoposide (1L durva + EP) in extensive-stage small cell lung cancer (ES-SCLC): Primary analysis of the phase 3 DeLLphi-305 trial
https://esmocongress.esmo.orgSource: Lung Cancers Today · x.com